Saturday, July 20, 2024


Galvani Bioelectronics Announces appointment of Dr. Raolat Abdulai as New Chief Medical Officer

Galvani Bioelectronics, a clinical-stage therapeutics company formed through a strategic partnership between GSK and Verily Life Sciences to develop targeted neuromodulation therapies, announced it...

Forma Medical Granted FDA Clearance For Optimal Plating System Enabling a Multi-Faceted Growth Strategy for MIS Forefoot Portfolio

Forma Medical Inc., a leading innovator in medical device technologies, is thrilled to announce the FDA 510(k) clearance for its groundbreaking OptimalMTP® Plating System....

Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation

Pulse Biosciences, Inc, a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology, announced that it has received the Breakthrough Device Designation...

FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss

Genentech, a member of the Roche Group announced the U.S. Food and Drug Administration (FDA) has approved the Vabysmo (faricimab-svoa) 6.0 mg single-dose prefilled...

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

ANI Pharmaceuticals, Inc. announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) and launched Naproxen...

Hot Topics